(Q33214198)

24 July 2017

1 reference

title

The economic burden of glaucoma and ocular hypertension: implications for patient management: a review (English)

1 reference

24 July 2017

1 reference

Jean-François Rouland

series ordinal

1

1 reference

24 July 2017

Gilles Berdeaux

series ordinal

2

1 reference

24 July 2017

Antoine Lafuma

series ordinal

3

1 reference

24 July 2017

language of work or name

1 reference

1 January 2005

1 reference

24 July 2017

1 reference

24 July 2017

22

1 reference

24 July 2017

4

1 reference

24 July 2017

315-321

1 reference

https://scigraph.springernature.com/pub.10.2165/00002512-200522040-00004

24 July 2017

0 references

cites work

Two-year double-masked comparison of bimatoprost with timolol in patients with glaucoma or ocular hypertension

1 reference

12 December 2020

Estimating the long-term visual field consequences of average daily intraocular pressure and variance : a clinical trial comparing timolol, latanoprost and travoprost

1 reference

12 December 2020

Wellcome Trust support for vision research

1 reference

12 December 2020

Resource use and costs of patients with glaucoma or ocular hypertension: a one-year study based on retrospective chart review in the Netherlands.

1 reference

12 December 2020

The projected increase in glaucoma due to an ageing population

1 reference

12 December 2020

Cost analysis of early trabeculectomy versus conventional management in primary open angle glaucoma

1 reference

12 December 2020

Consumption of glaucoma medication

1 reference

12 December 2020

Utility of predictive equations for estimating the prevalence and incidence of primary open angle glaucoma in the UK

1 reference

12 December 2020

Blindness, low vision, and other handicaps as risk factors attached to institutional residence

1 reference

12 December 2020

Health economics, economic evaluation, and glaucoma

1 reference

12 December 2020

The effects of new topical treatments on management of glaucoma in Scotland: an examination of ophthalmological health care

1 reference

12 December 2020

Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension

1 reference

12 December 2020

Costs of medical and surgical treatment of glaucoma

1 reference

12 December 2020

The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma.

1 reference

12 December 2020

Collaborative Initial Glaucoma Treatment Study: a summary of results to date

1 reference

12 December 2020

Learning to live with glaucoma: a qualitative study of diagnosis and the impact of sight loss

1 reference

12 December 2020

Cost effectiveness of screening for primary open angle glaucoma.

1 reference

12 December 2020

1 reference

12 December 2020

Cost considerations of medical therapy for glaucoma

1 reference

12 December 2020

Cost analysis of glaucoma medications: a 3-year review

1 reference

12 December 2020

The Economic Burden of Glaucoma in the UK

1 reference

12 December 2020

The cost-effectiveness of various modes of screening for primary open angle glaucoma

1 reference

12 December 2020

Patient preferences for eye drop characteristics: a willingness-to-pay analysis.

1 reference

12 December 2020

The Advanced Glaucoma Intervention Study (AGIS): 4. Comparison of treatment outcomes within race. Seven-year results

1 reference

12 December 2020

Prevalence of serious eye disease and visual impairment in a north London population: population based, cross sectional study

1 reference

12 December 2020

Number of people with glaucoma worldwide

1 reference

12 December 2020

An observational, retrospective two-year cost study in primary open-angle glaucoma and ocular hypertension in newly diagnosed patients

1 reference

12 December 2020

Medical therapy cost considerations for glaucoma

1 reference

12 December 2020

Cost-minimisation study of dorzolamide versus brinzolamide in the treatment of ocular hypertension and primary open-angle glaucoma: in four European countries

1 reference

12 December 2020

Projected impact of travoprost versus both timolol and latanoprost on visual field deficit progression and costs among black glaucoma subjects

1 reference

12 December 2020

Brisbane GPs' perceptions of screening for primary open-angle glaucoma.

1 reference

12 December 2020

Comparison of the diurnal ocular hypotensive efficacy of travoprost and latanoprost over a 44-hour period in patients with elevated intraocular pressure

1 reference

12 December 2020

Best practice treatment algorithm for primary open-angle glaucoma: implications for U.S. ophthalmology practice

1 reference

12 December 2020

Screening models for glaucoma

1 reference

12 December 2020

Changes in medical and surgical treatments of glaucoma between 1997 and 2000 in France

1 reference

12 December 2020

10.2165/00002512-200522040-00004

Identifiers

DOI

1 reference

Dimensions Publication ID

24 July 2017

0 references

1 reference